Overview of expanded sterile PDS capabilities across North America and Europe

Sterile injectable development requires specialized expertise, appropriate containment, and flexible manufacturing capacity to support evolving molecule types and delivery formats.

This overview highlights sterile product development service (PDS) capabilities across four sites in North America and Europe: Greenville, NC; Plainville, MA; Ferentino, Italy; and Monza, Italy. Capabilities include development and fill-finish for liquid and lyophilized vials, as well as prefilled syringes and cartridges.

Download the overview to review site capabilities, supported presentations, tox levels, and batch size ranges.